Leukemia & MDS
“Leukemia & MDS” was moderated byÂ
— 6 October, 2022
“Leukemia & MDS” was moderated byÂ
“Drug Development for Blood Disorders”
“Tackling the Tumor Microenvironment
Cantor’s 2022 brain week continues
Managing Director and Senior Biotech
“Cell Therapy in Solid Tumors”
“Trends and Challenges in Immuno-Oncology”
“Resistant to Resistance: Approaches
“Building Combinations: What are
“Predictive Biomarkers, Sequencing,
“Innovation is the Name of the Game: